Name
PUBLIC HEALTH PARALLEL 1 - Interventions to prevent viral hepatitis
Date & Time
Wednesday, March 19, 2025, 8:30 AM - 10:00 AM
Speakers
Saeed Akhter, PAF Hospital
Ewan Colman, University of Bristol
Benjamin Cowie, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute
Andrew Mendlowitz, Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network
Joan Mutyoba, Makerere University School pf Public Health
Julie bruneau, Université de Montreal
Ewan Colman, University of Bristol
Benjamin Cowie, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute
Andrew Mendlowitz, Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network
Joan Mutyoba, Makerere University School pf Public Health
Julie bruneau, Université de Montreal
Description
- Prevention of hepatitis B and D (including PMTCT- increasing HBV birth dose, novel strategies to treat any woman HbsAg+ if no HBV DNA or birth dose available) Ben Cowie
- Prevention of hepatitis C (focus on PWID – known interventions that are effective, such as opioid agonist treatment and syringe service programs) Julie Bruneau
- Oral Presentation: MODELING THE EFFECT OF TARGETED INTERVENTIONS ON THE SPREAD OF HEPATITIS C THROUGH A NETWORK OF PEOPLE WHO INJECT DRUGS IN KENYA Ewan Colman
- Oral Presentation: OPTIMIZING TESTING AND TREATMENT STRATEGIES FOR HEPATITIS C ELIMINATION IN PUNJAB, PAKISTAN; REPORT FROM HEPATITIS PREVENTION AND TREATMENT PROGRAM Saeed Akhter
- Oral Presentation: IMPACT OF A TREATMENT PEER-SUPPORT MODEL ON HEPATITIS B SCREENING AND LINKAGE TO INTEGRATED HIV/HBV CARE IN A HIGH BURDEN HBV SETTING IN NORTHERN UGANDA Joan J. Mutyoba
- Oral Presentation: CHARACTERIZING ENGAGEMENT IN HEPATITIS C VIRUS TESTING AND CARE FOR INFANTS BORN TO PERSONS WHO TEST POSITIVE FOR HCV IN ONTARIO, CANADA Andrew B. Mendlowitz
- Q&A